Liquid Biopsy After Resection Of Pancreatic Adenocarcinoma And Its Relation To Oncological Outcomes. Systematic Review And Meta-Analysis

Pancreatic ductal adenocarcinoma (PDAC) is the seventh cause of cancer-related death worldwide and third place in Europe [1,2]. The actual 5-year survival rate is 12% [3]. This low survival rate is mainly due to late diagnosis, aggressive biology and resistance to current chemotherapy regimens [4 –7]. Only 20% are resectable at diagnosis; despite surgical resection, approximately 80% recurred. Furthermore, several factors may contribute to the recurrence of PDAC after resection, such as R1 status (
Source: Cancer Treatment Reviews - Category: Cancer & Oncology Authors: Tags: Systematic or Meta-analysis Studies Source Type: research